Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response.
about
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathologyA combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotypeThe Soluble Plasminogen Activator Receptor as a Biomarker on Monitoring the Therapy Progress of Pulmonary TB-AFB(+) PatientsMeasuring soluble ICAM-1 in African populations.Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatmentFeedback-based, system-level properties of vertebrate-microbial interactions.Ethnic variation in inflammatory profile in tuberculosis.T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosisSerum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.Granzyme B-expressing neutrophils correlate with bacterial load in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques.Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection.Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report.Biomarkers of latent TB infection.Surrogate markers of infection: interrogation of the immune system.Immunological biomarkers of tuberculosis.Inflammation and tuberculosis: host-directed therapies.Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis.Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples.Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.Predicting tuberculosis treatment outcome using metabolomics.Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis.Cervical tuberculous lymphadenitis in the elderly: comparative diagnostic findings.High Frequencies of Caspase-3 Expressing Mycobacterium tuberculosis-Specific CD4+ T Cells Are Associated With Active Tuberculosis.
P2860
Q28389823-5E8A29E4-3144-4673-B88E-5FB43F1ABCA0Q33626683-0F9CB196-28A9-4377-BE3A-0A5E103E6C1AQ34125133-E1977746-E160-4F47-8CFF-55458CEC0DBCQ34261904-CFC6B560-838E-4EB6-9B1E-106DEFF7BDB9Q34301551-E986E533-021D-42C1-9B76-1F3E63778E54Q34399577-61854A0F-24B6-4B72-B700-BC6F32736CDEQ34598046-13D06F86-760B-4AD1-9D4B-C809546D94A0Q34819594-C6ACA56F-4836-459C-8E28-5BCCBC0EE9B9Q35164131-C2F0B3B1-4D1B-4D9B-A9C3-B1ACCC6FA089Q35906959-40BBBE13-BD79-4BB6-9EB6-31E786137D42Q36062297-FD712B01-B798-45A4-AE66-1A6FE949E512Q36237421-D674BAF4-D6F1-48FB-9D2A-375ED88E0A3FQ36953120-685F89CD-C4FB-4DD8-8E33-4B1552AAE443Q37227589-3CCB6F86-8D11-4677-8B2C-71512E599B93Q37755029-7D37986B-9DE5-49E2-87A5-55F9FDD6A861Q37862743-087C844C-AEA7-44FE-BEF2-181378087472Q37862987-4FB71135-B5B7-4E0D-9709-6399835FD826Q38203352-7909063E-0383-4D1C-9939-C6B9D703E390Q38221214-E0E04CB7-473B-49B7-99C2-B33DFF15060CQ40488517-274E7502-7108-45AA-AE80-9F77466D7914Q47104871-2704A7DA-648B-46E6-96A3-5A9625406634Q47139711-42BD9D2A-2979-4C56-B66D-7156D5C52EB2Q49668458-2D0AE8B4-BB99-4481-8BD2-E46D3EC7E7D8Q51838282-48DC2B7D-85E9-4079-959C-5D01CD690FA9Q54451804-9AAE13AC-965E-474D-BC4D-6294E10733E7Q55516430-21AE78EE-56FB-433C-8CFE-14C2322C9691
P2860
Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Immune parameters as markers o ...... culosis chemotherapy response.
@en
Immune parameters as markers o ...... culosis chemotherapy response.
@nl
type
label
Immune parameters as markers o ...... culosis chemotherapy response.
@en
Immune parameters as markers o ...... culosis chemotherapy response.
@nl
prefLabel
Immune parameters as markers o ...... culosis chemotherapy response.
@en
Immune parameters as markers o ...... culosis chemotherapy response.
@nl
P2093
P50
P921
P1433
P1476
Immune parameters as markers o ...... culosis chemotherapy response.
@en
P2093
Hanne Veenstra
Nchinya Bennedict Bapela
Paul van Helden
Robert Gie
P304
P356
10.1016/J.JINF.2008.02.007
P577
2008-03-21T00:00:00Z